Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Scrip Awards
Partnered Content
Scrip Asia 100
Report Store
Ask The Analyst
PItCH
PDF Library
RSS Feeds
Subscribe
Advertise
UsernamePublicRestriction

Shanghai Fosun Pharmaceutical Group Co. Ltd.

Division of Fosun International Ltd.
www.fosunpharma.com/en

Latest From Shanghai Fosun Pharmaceutical Group Co. Ltd.

Bookmark
  • Analysis

Global Top Three Trade Places As Going Gets Tough, Especially In The US

By Aidan Fry

Mylan has moved up to become the world’s leading generics, biosimilars and OTC player, according to Generics Bulletin’s newly compiled global rankings. Sandoz has surpassed troubled Teva into second spot, but is set to surrender that position once it sells its US solid-dose and dermatology business to India’s Aurobindo, which has already moved into the global top 10.

Sales & Earnings Companies
Bookmark
  • News

International Demand For Robotic Surgery Drives Intuitive Surgical’s Revenues Up 21% in Q2

By Reed Miller

Intuitive Surgical reported on 18 July that worldwide da Vinci procedures were up about 17% in the second quarter of 2019 compared to the same period of 2018. While the US still accounts for the majority of Intuitive’s revenue, procedure volume outside the US is growing faster, especially in Asia.

Companies Sales & Earnings
Bookmark
  • Analysis

Double Approval Boost For Dova’s Doptelet But EU Licensee Still Sought

By Alex Shimmings

A first approval in the EU and an expanded US label for Dova’s TPO product should alter the its sales trajectory – all it needs now is an EU partner.

Approvals Companies
Bookmark
  • News

ReNeuron's Cell Therapies Attract Fosun Pharma, A Leading Regenerative Medicines Developer

By John Davis

The UK cell therapy biotech ReNeuron has attracted the healthcare group, Fosun Pharma, which is building up a leading position in regenerative medicine, to develop and commercialize its products in China.

 

Deals Regenerative Medicine
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By